Two companies will invest combined $34.4M in St. Joseph facilities


Boehringer Ingelheim Corp., a company in the Kansas City Animal Health Corridor, and LifeLine Foods, a corn processor, have committed to investing a combined $34.4 million in life sciences in St. Joseph.

Boehringer Ingelheim will invest about $22.4 million to increase its capacity to manufacture vaccines for livestock at its St. Joseph campus.

On Monday, the St. Joseph City Council will consider granting Chapter 100 sale-leaseback incentives. The project also will receive incentives from the KCP&L…

Previous Oregon nixes forced opioid tapers for back pain, declines to cover 5 other conditions
Next Downtown Denver, by the numbers: 26,000 residents, 120 new tech companies, $3 billion in investment